The suberoylanilide hydroxamic acid (SAHA), an inhibitor of histone deacetylase, induces autophagy through the negative regulation of the AKT/mTOR signaling, and inhibits cell proliferation, promoting apoptosis in glioblastoma CSCs. The gene discussed is MTOR; the disease is glioblastoma.